Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Wong

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
Nature Medicine|July 1, 2026
Innate immune responsiveness predicts enhanced cellular immunity and symptomatic disease after controlled human influenza infectionLoukas Papargyris, Jiayun Xu, Claire Broderick, et al.
Nature Communications|April 26, 2020
Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenograftsKwanghee Kim, Wenhuo Hu, François Audenet, et al.
Vaccine|September 6, 2024
Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trialXuan Ying Poh, Anthony Torres-Ruesta, Terence Yoong, et al.
Ebiomedicine|August 13, 2024
First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trialXuan Ying Poh, I Russel Lee, Chee Wah Tan, et al.
The Lancet Regional Health. Western Pacific|May 1, 2023
Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variantMatthew Zirui Tay, Yun Shan Goh, Siew-Wai Fong, et al.
Journal of Medical Virology|October 28, 2022
Efficient recall of SARS-CoV-2 variant-reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boostersAngeline Rouers, Nathan Wong, Yun Shan Goh, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
Nature Medicine|July 1, 2026
Innate immune responsiveness predicts enhanced cellular immunity and symptomatic disease after controlled human influenza infectionLoukas Papargyris, Jiayun Xu, Claire Broderick, et al.
Nature Communications|April 26, 2020
Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenograftsKwanghee Kim, Wenhuo Hu, François Audenet, et al.
Vaccine|September 6, 2024
Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trialXuan Ying Poh, Anthony Torres-Ruesta, Terence Yoong, et al.
Ebiomedicine|August 13, 2024
First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trialXuan Ying Poh, I Russel Lee, Chee Wah Tan, et al.
The Lancet Regional Health. Western Pacific|May 1, 2023
Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variantMatthew Zirui Tay, Yun Shan Goh, Siew-Wai Fong, et al.
Journal of Medical Virology|October 28, 2022
Efficient recall of SARS-CoV-2 variant-reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boostersAngeline Rouers, Nathan Wong, Yun Shan Goh, et al.
Pageof 10